Much research is being conducted recently using nanoparticle formulations of chemotherapeutics as well as pain relief meds. NIOSH and the Navy Public Health center have described the use of N 100’s as respiratory protection when working with nanoparticles, and formulations.
My question is-
When evaluating animal research protocols involving formulations on the nanoscale such as chemotherapeutics, is anyone requiring N 100’s when the task isinjecting the medication, as opposed to actually formulating it? One argument I hear from researchers is that their primary concern is autoinjection, which is why they have no problem with wearing gloves, but they would rather not wear a respirator.
Anyone involved in such risk assessment?
-Stefan Wawzyniecki, CIH, CHMM
University of Connecticut
Previous post | Top of Page | Next post